Literature DB >> 28962081

MiRNA-155 promotes proliferation by targeting caudal-type homeobox 1 (CDX1) in glioma cells.

Lei Yang1, Conghui Li1, Fang Liang2, Yakun Fan2, Shiyang Zhang3.   

Abstract

MicroRNAs (miRNAs) play important roles in the tumorigenesis of glioma. Recent studies showed that miR-155 expression was increased in types of cancer, including glioma. However, the underlying mechanism of miR-155 on glioma is still unclear. In the present study, expression of miR-155 and caudal-type homeobox 1 (CDX1) was determined in glioma tissues by qRT-PCR, and the regulatory axis was further studied in glioma cells. We showed that miR-155 expression was significantly increased in glioma tissues while CDX1 expression was decreased. Correlation analysis revealed that miR-155 was negatively correlated with CDX1 expression in glioma tissues. Moreover, Kaplan-Meier analysis indicated that patients with high miR-155 expression had a poor overall survival. In addition, our results showed that the translation of CDX1 expression could be suppressed by miR-155 mimics. And miR-155 mimics promoted glioma cell proliferation could be reversed by CDX1 overexpression. In vivo assay, we showed that miR-155 overexpression promoted the progress of tumor formation. Therefore, we suggested that miR-155 might promote glioma cell growth partially by targeting CDX1, which provided a novel therapeutic strategy for glioma patients.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Caudal-type homeobox 1 (CDX1); Glioma; Proliferation; miR-155

Mesh:

Substances:

Year:  2017        PMID: 28962081     DOI: 10.1016/j.biopha.2017.08.088

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis.

Authors:  Bin Li; Haikang Zhao; Jianming Song; Fenglu Wang; Mingsheng Chen
Journal:  Hum Cell       Date:  2019-11-12       Impact factor: 4.174

Review 2.  Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target.

Authors:  Seyed Hamidreza Rastegar-Moghaddam; Alireza Ebrahimzadeh-Bideskan; Sara Shahba; Amir Mohammad Malvandi; Abbas Mohammadipour
Journal:  Cell Mol Neurobiol       Date:  2022-02-02       Impact factor: 5.046

Review 3.  Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.

Authors:  Dinh-Duc Nguyen; Suhwan Chang
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

4.  Lnc HAGLR Promotes Colon Cancer Progression Through Sponging miR-185-5p and Activating CDK4 and CDK6 in vitro and in vivo.

Authors:  Weixuan Sun; Wenting Nie; Zhaoyi Wang; Haolong Zhang; Yezhou Li; Xuedong Fang
Journal:  Onco Targets Ther       Date:  2020-06-22       Impact factor: 4.147

5.  Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells.

Authors:  Roberta Milani; Eleonora Brognara; Enrica Fabbri; Alex Manicardi; Roberto Corradini; Alessia Finotti; Jessica Gasparello; Monica Borgatti; Lucia Carmela Cosenza; Ilaria Lampronti; Maria Cristina Dechecchi; Giulio Cabrini; Roberto Gambari
Journal:  Int J Oncol       Date:  2019-05-23       Impact factor: 5.650

6.  Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis.

Authors:  Ying Jin; Ji-Liang Li
Journal:  Chin Med J (Engl)       Date:  2019-07-20       Impact factor: 2.628

Review 7.  Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future.

Authors:  Fabio Nicolini; Martine Bocchini; Giuseppe Bronte; Angelo Delmonte; Massimo Guidoboni; Lucio Crinò; Massimiliano Mazza
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

8.  Propofol Inhibits the Migration and Invasion of Glioma Cells by Blocking the PI3K/AKT Pathway Through miR-206/ROCK1 Axis.

Authors:  Dongmei Wang; Tao Yang; Junqi Liu; Yafei Liu; Na Xing; Juan He; Jianjun Yang; Yanqiu Ai
Journal:  Onco Targets Ther       Date:  2020-01-14       Impact factor: 4.147

9.  Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.

Authors:  Chunyu Zhang; Haitao Liu; Pengfei Xu; Yinqiu Tan; Yang Xu; Long Wang; Baohui Liu; Qianxue Chen; Daofeng Tian
Journal:  BMC Cancer       Date:  2021-03-09       Impact factor: 4.430

10.  A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.

Authors:  Jian-Hua Zhang; Ruiqin Hou; Yuhualei Pan; Yuhan Gao; Ying Yang; Wenqin Tian; Yan-Bing Zhu
Journal:  J Cell Mol Med       Date:  2020-05-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.